[AsiaNet] Jemincare initiates phase I clinical trial of anti-SARS-CoV-2
neutralizing antibody JMB2002
(NANCHANG, China, Jan. 20, 2021 AsiaNet=연합뉴스) On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002).
Preclinical studies of JMB2002 including pharmacology and toxicity were carried out systemically. The drug metabolism, safety and efficacy were well performed. In early studies, it was found that JMB2002 could effectively neutralize live virus infection of Vero E6 cells. What's more, JMB2002 showed potent binding and blocking activities to the spike glycoproteins of mutant viruses.
While most of the SARS-CoV-2 neutralizing antibodies in clinical trial are produced from cell pool, the product for clinical trial of JMB2002 is produced from high yield stable cell line, that ensure the consistency and stability of clinical samples. JMB2002 is derived from naive human B cell antibody library of healthy donors. With the powerful phage-to-yeast platform, researchers quickly pinpoint the ideal candidates from over 10 billion antibody molecules in 19 days.
As one of the large-scale and modernized pharmaceutical groups in China, Jemincare Group, making breakthrough achievements in recent 2 years, has focused on the R&D of new drugs over the years with R&D pipeline for treating diseases in cancer, central nervous system, respiratory system, cardiovascular and cerebrovascular systems. In 2018, Jemincare established its Research Institute in Shanghai Zhangjiang Science City and has recruited over 400 R&D scientists in 5 research centers for development of innovative drugs including biologics, novel small molecules, novel drug delivery system, generic drugs and traditional Chinese medicines.
For more information, please visit
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
출처 : 아시아넷 보도자료
- '덩샤오핑의 후계자' 장쩌민 전 중국 국가주석 사망
- 정부, 업무복귀 안하면 '안전운임제 완전폐지' 경고
- 생산 중단, 출하 차질, 건설 스톱…파업 7일째 현장 아우성
- '지하철 파업' 서울교통공사 노사 오늘 오후 7시 교섭 재개(종합) | 연합뉴스
- 민주, 이상민 해임건의안 발의…尹 거부시 내주 탄핵안
- 중러 군용기 8대, 카디즈 3차례 진입 이탈…F-15K 등 출격(종합) | 연합뉴스
- [월드컵] '벤투호 스타' 조규성에 쏟아지는 관심…해외서도 주목
- 정부, 임기 6개월 남은 해병대사령관 교체…김계환 내정(종합3보) | 연합뉴스
- 곽상도, '아들 퇴직금 50억' 징역 15년 구형에 "황당"
- 전력 도매가 상한제 내일부터 시행…산업장관 승인(종합) | 연합뉴스